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Abstract
Background: TBX21 (T cell specific T-box transcription factor) and HLX1 (H.20-like homeobox 1) are crucial transcription
factors of TH1-cells, inducing their differentiation and suppressing TH2 commitment, particularly important for early life
immune development. This study investigated the influence of TBX21 and HLX1 single nucleotide polymorphisms (SNPs),
which have previously been shown to be associated with asthma, on TH1/TH2 lineage cytokines at birth.
Methods and Findings: Cord blood mononuclear cells (CBMCs) of 200 neonates were genotyped for two TBX21 and three
HLX1 SNPs. CBMCs were stimulated with innate (Lipid A, LpA; Peptidoglycan, Ppg), adaptive stimuli (house dust mite
Dermatophagoides pteronyssinus 1, Derp1) or mitogen (phytohemagglutinin, PHA). Cytokines, T-cells and mRNA expression
of TH1/TH2-related genes were assessed. Atopic diseases during the first 3 years of life were assessed by questionnaire
answered by the parents. Carriers of TBX21 promoter SNP rs17250932 and HLX1 promoter SNP rs2738751 showed reduced
or trendwise reduced (p#0.07) IL-5, IL-13 and TNF-a secretion after LpA-stimulation. Carriers of HLX1 SNP rs2738751 had
lower IL-13 levels following Ppg-stimulation (p=0.08). Carriers of HLX1 exon 1 SNP rs12141189 showed increased IL-5 (LpA,
p=0.007; Ppg, p=0.10), trendwise increased IL-13 (LpA), higher GM-CSF (LpA/Ppg, p#0.05) and trendwise decreased IFN-c
secretion (Derp1+LpA-stimulation, p=0.1). Homozygous carriers of HLX1 promoter SNP rs3806325 showed increased IL-13
and IL-6 (unstimulated, p#0.03). In carriers of TBX21 intron 3 SNP rs11079788 no differences in cytokine secretion were
observed. mRNA expression of TH1/TH2-related genes partly correlated with cytokines at protein level. TBX21 SNP
rs11079788 carriers developed less symptoms of atopic dermatitis at 3 years of age (p=0.03).
Conclusions: Polymorphisms in TBX21 and HLX1 influenced primarily IL-5 and IL-13 secretion after LpA-stimulation in cord
blood suggesting that genetic variations in the transcription factors essential for the TH1-pathway may contribute to
modified TH2-immune responses already early in life. Further follow-up of the cohort is required to study the
polymorphisms’ relevance for immune-mediated diseases such as childhood asthma.
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Introduction
Asthma and inflammatory diseases are induced by a complex
interplay of genetic and environmental factors influencing early
immune responses [1,2,3]. Modulation of the immune system in
early life via innate stimuli may play an essential role in preventing
allergic responses [4], as shown in farm children, which are
exposed to microbial innate stimuli and have a lower prevalence of
allergic diseases [5].
TH1/TH2 imbalance can lead to different inflammatory
conditions and has been described in several immune-mediated
diseases including asthma [6]. TH1 and TH2 cell lineages are
controlled by cell-specific transcription factors (TFs) [7]. TBX21, is
a specific TF of TH1-cells, which promotes their differentiation
and proliferation and suppresses TH2-cell development. It
activates the expression of the TH1 hallmark cytokine INF-c and
represses IL-4 production in developing TH2-cells [8]. TBX21
polymorphisms were associated with airway hyperresponsiveness
in asthma [9] and increased risk for childhood asthma [10].
TBX21 interacts closely with HLX1, another TH1 transcription
factor. The interaction between TBX21 and HLX1 is required to
induce maximal IFN-c secretion [11]. Both genes have the
capacity to revert TH2 cell commitment of T cells already
expressing TH2 cytokines [11]. Further downstream activation of
TH1 and TH2 cytokines is regulated tightly by these transcription
factors [8,12,13]. Like TBX21, polymorphisms in HLX1 have also
been significantly associated with the development of childhood
asthma [14]. Functional studies on some of these genetic variants
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e31069already demonstrated their putative functional relevance [10,14].
In general, lineage-specific TFs control other TFs and genes that
encode for cytokines [7].
Cytokine regulation has shown to be crucial for later development
of immune-mediated diseases such as asthma. Thus, it is of particular
interest in this context to study early life immune modulation.
Cytokines as important mediators in the development of allergies are
already modulated during pregnancy, and a TH2-dominated
cytokine pattern can be detected in cord blood [15,16,17,18].
We hypothesized that polymorphisms in these TH1-specific TFs
influence T cell immune responses already at birth. We aimed to
study two TBX21 (rs17250932, rs11079788) and three HLX1
(rs2738751, rs3806325, rs12141189) polymorphisms, which have
previously been associated with risk or protection from childhood
asthma. We investigated whether these SNPs have an impact on
cytokine secretion patterns and mRNA expression of TH1/TH2-
related genes. We further assessed the impact of the atopic status of
the mother as strong predictor for the development of childhood
allergic diseases [15]. Additionally, we investigated the development
of atopic diseases of the children during the first 3 years of life.
Methods
Ethics Statement
Written informed consent was obtained from the mothers for
participation. Approval was obtained from the local human
research committee of the Bavarian Ethical Board, LMU Munich,
Germany.
Population characteristics
Fetal cord blood was obtained from neonates (n=200) born in the
Munich metropolitanarea, Germany. Informedconsent wasgivenby
the mothers for participation in the study, including cord blood
collection. The enrolment period was from July 2005 until September
2007. Inclusion criteria comprised healthy neonates and mothers
with uncomplicated pregnancies. Exclusion criteria included preterm
deliveries and perinatal infections. Maternal atopy was defined as
doctor’s diagnosis of asthma and/or eczema and/or hay fever. In
addition, total and specific IgE (Radio-Allergo-Sorbent Test) was
measured. A positive specific IgE was defined as 1 or more positive
reactions ($0.35 IU/ml) to a panel of 20 common allergens.
Follow-up at age 3 years
A follow-up at the age of 3 years was performed. The data were
assessed by detailed questionnaires answered by the parents.
Wheeze was defined by wheezy symptoms in the first 3 years.
Atopic dermatitis (AD) was defined by symptoms of AD in the first
3 years, and skin manifestations of food allergy were noted. A
positive allergy test was defined by parental report of a positive
skin Prick test or blood test with at least one positive test to one of
the 20 common inhalant or food allergens.
Polymorphisms selection and genotyping
Based on previous studies, 5 polymorphismsin TBX21 and HLX1
were selected for this analysis due to their association with asthma
and their putative functional implications [10,14]. Genotyping was
performed by Matrix-assisted laser desorption/ionization time-of-
flight mass spectrometry (Sequenom Inc., San Diego, CA, USA).
Polymerase chain reaction assays and associated extension reactions
were designed with the SpectroDESIGNER software (Sequenom
Inc.). All amplification and extension reaction conditions have been
previously described [19]. Deviations from Hardy–Weinberg
Equilibrium were assessed for quality control of genotyping
procedures (Table 1). Of note, wild type (WT) refers to WT alleles
in absence of the particular polymorphic allele under study.
Real-time quantitative RT-PCR
Total RNA was isolated from CBMCs with TRI reagent, cDNA
synthesis was performed using reverse transcriptase (Invitrogen,
Karlsruhe, Germany). Vector NTI advance10 (Invitrogen, Karls-
ruhe, Germany) was used for specific primer pairs design (18S,
GATA3, STAT6, STAT6e, TBX21, HLX1, IRF1). Gene-specific
PCR-products were measured continuously by means of iCycler
Real-Time PCR-Detection-System (Bio-Rad) for 40 cycles. Direct
detection of the PCR product was monitored by measuring the
increase in fluorescence caused by the binding of SYBR Green to
dsDNA. The threshold cycle (ct) of each target product was
determined and set in relation to the amplification plot of 18S (Dct).
The level of mRNA of each gene is described as gene expression.
Cytokine secretion
CBMCs, isolated freshly within 24 hours by Ficoll-Hypaque
density gradient, were stimulated with Lipid A (LpA, 0.1 mg/ml),
Peptidoglycan (Ppg, 10 mg/ml), allergen house dust mite (Derp1,
30 mg/ml), a combination of Derp1 and LpA (D+L) or phytohemag-
glutinin (PHA, 5 mg/ml) for 3 days and compared with unstimulated
cells as previously described [15]. Cytokine concentrations were
measured in supernatants by using the Human Cytokine-Multiplex-
Assay-Kit according to the manufacturer’s instructions (Bio-Rad,
Munich, Germany) by LUMINEX technology. The lower limits of
detection (pg/ml) were 1.8 (IL-5), 0.5 (IL-6), 3.0 (TNF-a), 0.21 (IL-13),
1.3 (IFN-c), 1.0 (GM-CSF). Non-detectable cytokine concentrations
were assigned to a value of 0.01 for inclusion into the analysis.
Table 1. Characteristics of the studied TBX21 and HLX1 polymorphisms.
Gene rs No.
Position in
relation to 1.ATG
Position in the gene
structure MAF (ISAAC
+) MAF (our cohort) P value HWE
TBX21 rs17250932 T21514C
y Promoter 0.16 0.22 0.5956
TBX21 rs11079788 C+9902T
y Intron 3 0.22 0.30 0.8273
HLX1 rs2738751 C21486G* Promoter 0.14 0.15 0.8804
HLX1 rs3806325 C21407T* Promoter 0.19 0.18 0.4744
HLX1 rs12141189 T+346C*
D Exon 1 0.25 0.25 0.4025
*Based on the National Center for Biotechnology Information GenBank sequence (accession no. AF217621).
yBased on the TBX21 sequence obtained from the SNPper database (http://snpper.chip.org).
+German children (total n=3099) from the cross-sectional International Study of Asthma and Allergy in Childhood phase II.
DSNP leads to an amino acid change. HWE=Hardy–Weinberg Equilibrium. MAF, Minor Allelle Frequency. HWE, Hardy-Weinberg Equilibrium.
doi:10.1371/journal.pone.0031069.t001
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Cells were analyzed by using 3-color flow cytometry (FACScan;
BD Biosciences, Heidelberg, Germany). For surface staining, 2 ml
of anti-human CD4–fluorescein isothiocyanate (FITC) and 1 mlo f
CD25–RPE-Cy5 (Dako Cytomation, Glostrup, Denmark), were
used. For isotype control 1 ml of IgG1-FITC (Dako Cytomation,
Glostrup, Denmark), and 0.5 ml of IgG2a RPE-Cy5 (BD
Biosciences) were added [4]. Data were analyzed with CellQuest
software (BD Biosciences), and postacquisition analysis was
performed with WinMDI 2.8 software (The Scripps Research
Institute, La Jolla, CA).
Statistical analysis
Non-parametric tests (Wilcoxon/Kruskal-Wallis) were used to
compare the median of cytokine concentrations, as these were
generally not normally distributed and could not be transformed to
normality. Data were reported as median, first and third quartile.
Chi
2 tests were used to evaluate categorical predictor variables.
Data for genetic analyses were analyzed with Kruskal-Wallis-test
(three groups). Based on previous reports which described
recessive effects for TH1-related SNPs, we have further analysed
the SNP effects using a recessive model. Due to the fact that gene
expression variables contained non-detectable measurements
(censored data), summary statistics such as the median and
quartiles was conducted by the Kaplan-Meier method [20].
Testing on group differences was performed by the generalized
Wilcoxon test [21]. Data were not adjusted for multiple testing as
this is an explorative study. In order to assess the role of maternal
atopy we performed stratified analysis for the CBMCs of the
neonates with or without maternal atopy. Statistical significance
was defined by p#0.05; data analysis was performed with SAS 9.2
(The SAS Institute, Cary, NC, USA).
Results
We assessed the effect of 5 genetic variants located in TH1
lineage transcription factors on cord blood immune responses of
200 neonates, namely TBX21 (rs17250932 and rs11079788) and
HLX1 (rs2738751, rs3806325 and rs12141189) (Table 1) which
have previously been related to the development or protection
from asthma [10,14]. The genotyping success rate was at least
97%. None of the polymorphisms deviated significantly from
Hardy-Weinberg Equilibrium.
TH2-related cytokine secretion upon innate stimulation
was modulated in carriers of TBX21 and HLX1
polymorphisms
Assessment of cytokine responses in CBMCs showed that
carriers of TBX21 SNP rs17250932 (promoter) and HLX1 SNP
rs2738751 (promoter) had decreased or trendwise decreased IL-5
and IL-13 after LpA and for the latter also decreased IL-13 after
Ppg-stimulation compared to wild-type (WT) and heterozygous
carriers (HT). TNF-a secretion was trendwise lower or significant
lower in carriers of TBX21 SNP rs17250932 and HLX1 SNP
rs2738751, respectively (Fig. 1).
On the other hand, increased IL-5, IL-13 and GM-CSF
secretion was observed in the carriers of HLX1 SNP rs12141189
(exon 1), after LpA and Ppg-stimulation, while the TH1-cytokine
IFN-c was trendwise downregulated after D+L-stimulation (Fig. 2).
Additionally we analyzed the polymorphisms using a recessive
model, as previous reports described recessive effects for TH1-
related SNPs. After applying the recessive model, the majority of
the findings achieved greater statistical significance (Table 2).
Carriersof HLX1 SNP rs3806325 (promoter), showed increased IL-
13 and IL-6 levels in unstimulated cells (Table 2), and no significant
changes were observed for other cytokines or following stimulation.
Carriers of the TBX21 SNP rs11079788 (intron 3) showed
significantly higher CD4
+CD25
+ cells (2.79%) in comparison to
the HT (2.38%) and WT (1.78%) in unstimulated cells. However
no significant changes in cytokine secretion were detected as for
the other four studied TH1-related polymorphisms. No statistically
differences were observed following PHA-stimulation for any of
the polymorphisms. Previously we have shown that two TLR2
polymorphisms were important for the modulation of T regulatory
cells at birth [22]. Assessing whether these TLR2 polymorphisms
have an additional effect in this study, we detected only 1–3
children with homozygous polymorphisms for both HLX1 and
TLR2 (Table S1). Thus, we can not disentangle potential effects of
TLR2 polymorphisms in our study.
Carriers of TBX21 and HLX1 polymorphisms showed
modulated mRNA expression of TH1/TH2 related genes
We assessed the effects of the SNPs on mRNA expression of
TH1/TH2 related genes, namely TBX21, HLX1, IRF1, GATA3,
STAT6 and STAT6e. We included gene expression data related to
the main findings at cytokine protein level. Carriers of TBX21
SNP rs17250932 showed lower STAT6e mRNA expression, in
unstimulated cells although the decrease at protein level of TH2/
proinflammatory cytokines was observed after innate stimulation
(Table 2)t. Carriers of TBX21 rs11079788 had increased TH2/
TH1 related genes GATA3 and also increased HLX1 and IRF1
mRNA expression in unstimulated cells, in parallel with increased
activated T cells (Table 2).
HLX1 rs3806325 SNP carriers showed increased GATA3 and
STAT6e mRNA expression following LpA-stimulation, in parallel
with higher IL-13 and IL-6 cytokine response, the latter in
unstimulated cells. HLX1 rs12141189 SNP carriers showed lower
TBX21 gene expression (D+L), in parallel with lower IFN-c
protein secretion. No significant changes at mRNA level were
detected for HLX1 rs2738751 SNP carriers (Table 2).
Maternal atopy showed no additional effect on the SNP-
induced immune modulation
Due to the relevance of maternal atopy on cord blood immune
responses [15], we further assessed whether the modulated
immune responses in SNP carriers were influenced by the atopic
status of the mother. However, in stratified analysis all observed
effects were of similar magnitude for children with and without
maternal atopy indicating no effect of maternal atopy in the
present study (data not shown). In addition, the Minor Allelle
Frequencies (MAF)of TBX21 and HLX1 SNPs differed only
sligthly in the CBMC of neonates from either atopic or non-atopic
mothers (Table 3).
Impact of TBX21 and HLX1 polymorphisms on health
outcomes
The cohort was followed up to the age of 3 years and symptoms
of atopic diseases and wheeze were assessed by questionnaires.
The distribution of children that developed atopic diseases within
the different TBX21 and HLX1 genotypes (WT, HT and SNP) is
described in the following: homozygous carriers of TBX21
rs11079788 SNP showed less symptoms of atopic dermatitis
(19%) compared to HT (23%) and WT (36%) (p=0.03). No
significant associations were observed for the other TBX21 and
HLX1 polymorphisms with wheeze, skin manifestation of food
allergy or atopic dermatitis at this time point.
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Data were shown in boxplots (first, third quartile, median), the whiskers indicate the maximum and minimum values, dots indicate outliers, analyzed
by Kruskal-Wallis-test. Values were shown in pg/ml. n (WT)=113, n (HT)=61, n (SNP)=10, and HLX1 rs2738751 n (WT)=135, n (HT)=45, n (SNP)=4.
doi:10.1371/journal.pone.0031069.g001
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e31069Figure 2. Cytokine secretion of wildtype, heterozygous and homozygous SNP carriers of HLX1 rs12141189. Data were shown in
boxplots (first, third quartile, median), the whiskers indicate the maximum and minimum values, dots indicate outliers, analyzed by Kruskal-Wallis-
test. Values were shown in pg/ml. n (WT)=104, n (HT)=68, n (SNP)=12.
doi:10.1371/journal.pone.0031069.g002
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In this study, we assessed the effect of single nucleotide
polymorphisms (SNPs) of TH1 transcription factors, namely
TBX21 and HLX1 on T cell lineages and in particular TH1/
TH2 cytokine secretion in cord blood. Carriers of TBX21 and
HLX1 polymorphisms showed modulated IL-5 and IL-13 (TH2)
cytokine secretion upon innate stimulation with Lipid A or
peptidoglycan in cord blood. TH1/TH2-related mRNA expression
partly correlated with cytokine secretion.
The influence of a child’s genotype on the development of
immune-mediated diseases such as allergic diseases has been
shown in several studies, e.g. for IRF1 or TLR polymorphisms
[22,23,24]. For TBX21 polymorphisms, several studies have
shown an association with the development of asthma [25,26,27]
indicating the relevance of TH1 TFs in TH2-associated allergic
diseases. Therefore we investigated the effect of SNPs in the TH1
pathway (TBX21 and HLX1) on primarily TH1 and TH2 cytokine
regulation early in life, a critical time window, which is relevant for
early immune maturation and subsequent determination of TH2-
mediated allergic diseases [28,29,30]. We detected a decrease of
IL-5 and a trend for decreased IL-13 secretion after LpA-
stimulation in homozygous carriers of TBX21 SNP rs17250932.
This decrease may potentially be explained by an overexpression
of TBX21. Indeed, it has previously been shown experimentally
that this polymorphism increases promoter activity [10]. Szabo et
al. have shown that expression of TBX21 in TH2-cells by retroviral
gene transduction leads to lower IL-4 and IL-5 [8]. Furthermore,
IL-13 mRNA expression and its promoter activity were suppressed
upon TBX21 expression suggesting a regulation of IL-13 at gene
transcription level [12]. In parallel, T-bet null mice showed
elevated production of IL-4, IL-5 and IL-13, and diminished
production of interferon-c [31]. In unstimulated conditions the
TBX21 SNP rs17250932 carriers showed reduced STAT6e mRNA
expression, which represents a STAT6 isoform (splice variant
including both intron 17 and intron 18) [32]. The second TBX21
SNP (rs11079788) investigated in our study was not associated
with any change in cytokine responses. Yet, homozygous carriers
Table 2. Effects of TBX21 and HLX1 polymorphisms on cytokine secretion, T cells and mRNA regulation.
Gene/rs number
Cytokine secretion/T cell
regulation P Overall P recessive model mRNA regulation P Overall
TBX21 rs17250932 IL-5 (LpA)Q 0.03 0.03 No changes with LpA -
IL-13 (LpA)Q 0.06 0.28 STAT6e (U)Q 0.01
TNF-a (LpA)Q 0.07 0.16
TBX21 rs11079788 CD4
+CD25
+ (U)q 0.04 0.23 GATA3 (U)q 0.08
HLX1 (U)q 0.02
IRF1 (U)q 0.01
HLX1 rs2738751 IL-5 (LpA)Q 0.05 0.02 No changes with LpA or Ppg -
IL-13 (LpA)Q 0.05 0.02
IL-13 (Ppg)Q 0.08 0.03
TNF-a (LpA)Q 0.04 0.01
HLX1 rs3806325 IL-13 (U)q 0.005 0.003 GATA3 (LpA)q 0.003
IL-6 (U)q 0.03 0.05 STAT6e (LpA)q 0.007
HLX1 rs12141189 IL-5 LpAq 0.007 0.002 TBX21 (D+L)Q 0.02
IL-13 LpAq 0.1 0.04
GM-CSF LpAq 0.03 0.009
IL-5 (Ppg)q 0.1 0.09
GM-CSF (Ppg)q 0.05 0.02
IFN- c (D+L)Q 0.1 0.03
LpA=Lipid A; Ppg=Peptidoglycan and U=unstimulated, D+L=Dermatophagoides pteronyssinus 1 and Lipid A;
q: expression upregulated;
Q: expression downregulated. P values analyzed by Kruskal-Wallis-test (overall, 3 categories) or Wilcoxon-test (recessive model, 2 categories). Genotype comparison
includes the comparison of the respective genotype groups used for statistical analysis of mRNA expression; statistics performed by generalized Wilcoxon test.
Significance (p#0.05) is marked in bold.
doi:10.1371/journal.pone.0031069.t002
Table 3. Minor Allele Frequency (MAF) in children of atopic
and non-atopic mothers.
Gene/rs number Maternal atopy MAF
TBX21 rs17250932 No 0.25
Yes 0.17
TBX21 rs11079788 No 0.32
Yes 0.25
HLX1 rs2738751 No 0.15
Yes 0.15
HLX1 rs3806325 No 0.16
Yes 0.21
HLX1 rs12141189 No 0.20
Yes 0.23
Minor Allele Frequency of TBX21 and HLX1 polymorphisms in children of atopic
and non atopic mothers.
doi:10.1371/journal.pone.0031069.t003
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increased expression of GATA3, HLX1, IRF1 mRNA expression,
representing TH1 as well as TH2-genes.
Similar to TBX21 rs17250932, homozygous carriers of HLX1
SNP rs2738751, showed lower TH2 and inflammatory cytokine
secretion (IL-5, IL-13 and TNF-a) after LpA-stimulation.
Carriers of HLX1 polymorphism rs12141189 showed increased
TH2 cytokines such as IL-5, IL-13 and also GM-CSF following
innatestimulation(LpA orPpg). Inparallel tohigher TH2cytokines,
we detected also lower TH1 IFN-c secretion and lower TBX21
mRNA expression. This could lead to HLX1 dowregulation, as
HLX1 can be induced by TBX21 [11]. This increase of TH2
cytokines at birth in our study may potentially be in contrast with an
asthma-protective effect observed in school-age children [14].
Although without stimulation no differences at mRNA-level of
TH1/TH2-relatedgenesweredetected,theLpA-inducedincrease of
GATA3 and STAT6 mRNA expression in homozygous carriers of
the HLX1 SNP rs3806325 may be supportive of a TH2-dominated
immune response. However different influences on immune
maturation during childhood may modify the T cell lineage fate
overtime.Thus,adirectcomparisonbetweenfindingsincordblood
and school-age children needs to be interpreted with caution.
Homozygous carriers of HLX1 SNP rs3806325, which was
previously associated with an enhanced risk for asthma, especially
non-atopic asthma in childhood (14), showed increased levels of
IL-13 (TH2) and additionally enhanced IL-6 secretion in this cord
blood study. Previous functional studies have demonstrated that
this polymorphism significantly influences HLX1 gene expression
levels due to an altered transcription factor binding to the HLX1
promoter, indicating its potential functional relevance [14].
Results comparing HLX1 SNP carriers vs heterozygous and WT
carriers became more significant when applying the recessive
model, which compares the homozygous SNP carriers vs
heterozygous carriers and wild type. Overall, immune develop-
ment is influenced by a variety of factors over time, and cord blood
responses may not be translated to childhood atopic phenotypes
without taking additional regulatory factors into account. It is
likely that certain genotypes may be more relevant than others and
that the interplay with specific environmental exposures will
impact TH cell lineages and disease development differently.
In our study most of the effects of TBX21 and HLX1 polymorphisms
of TH1 pathway were observed upon LpA-stimulation, partly upon
Ppg-stimulation and almost no differences were observed following
Derp1-stimulation. Thus, the effects seem to be influenced by innate
immune regulation, mainly via TLR4-stimulation. For further
functional explanation, more detailed studies are required.
Furthermore, we described in our previous studies that maternal
atopy modulated cord blood immune responses [15,22]. Yet, in
stratified analysis in this study, all observed effects were of similar
magnitude for children with and without maternal atopy.
In regards to allergic outcomes assessed at age 3 years, one
TBX21 polymorphism was associated with less symptoms of atopic
dermatitis. Therefore, further investigations on both TBX21 and
HLX1 polymorphisms are required in larger cohorts to confirm the
effects of the polymorphisms on atopic diseases in childhood. It
may be of particular interest to investigate children at risk for
atopic diseases, in order to disentangle the effects of the SNPs on
early immune development and subsequent disease.
Additional points need to be considered for interpretation of our
data. The results were not adjusted for multiple testing as this is an
explorative study and further replication by other studies rather than
correctionformultipletesting isrequired.Anotherimportantpointis
the assessment of cytokines in bulk culture due to logistic possibilities
and low cell numbers per child. Thus, we were not able to clearly
differentiate the origin of the secreting cell. Additionally, we do not
have details about leukoyte subsets available. The low frequency of
SNPsresulted inlow numbers of homozygous carriers of the SNPsin
our cohort, therefore some findings could possibly be masked or
power was limited due to the number of affected children.
The strength of this study is a detailed investigation of the early
immune system regarding TH-cell lineages at mRNA and cytokine
protein level in relation to TH1 genotypes in a well documented
birth cohort, including the follow-up for atopic diseases until the
age of 3 years. It reveals that polymorphisms in crucial
transcription factors of TH1 cells lead to alterations in the TH2
pathway already in early life. The further follow-up of our cohort
will help to elucidate which of these children will also develop
atopic diseases and/or asthma and whether the TBX21 and HLX
genotypes have an impact on their later immune development.
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